Navigation Links
Renovis Reports Third Quarter 2007 Financial Results
Date:11/6/2007

7 $2,150 $8,450 $8,278

Operating expenses:

Research and development 5,851 6,858 20,059 20,712

General and administrative 5,654 4,016 17,672 11,649

Total operating expenses 11,505 10,874 37,731 32,361

Loss from operations (10,188) (8,724) (29,281) (24,083)

Other income 1,085 1,290 3,234 3,683

Net loss (9,103) (7,434) (26,047) (20,400)

Basic and diluted net

loss per share $(0.31) $(0.25) $(0.88) $(0.70)

Shares used to compute

basic and diluted net

loss per share 29,729,785 29,303,319 29,626,630 29,153,777

RENOVIS, INC.

Condensed Balance Sheets

(in thousands)

September 30, December 31,

2007 2006

(unaudited) (1)

Assets:

Cash and cash equivalents $41,716 $41,958

Short-term investments 43,976 57,149

Prepaid and other current assets 1,209 928

Total current assets 86,901 100,035

Property and equipment, net 5,640 7,052

Other long-term assets 235 214

$92,776 $107,301

Liabilities and stockholders' equity

Current liabilities $9,959 $10,531

Long-term liabilities 2,152 3,684

Stockholders' equity 80,665 93,086

$92,776 $107,301

(1) Derived from audited financial
'/>"/>

SOURCE Renovis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Renovis to Present at CIBC World Markets Healthcare Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...
(Date:12/15/2009)... three Department of Energy (DOE) bio-energy research centers, has ... valuable intellectual property. , ... ... Surety, LLC , the leading provider of ... Joint BioEnergy Institute (JBEI), one of three Department of ...
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3
... SuperGen Inc.,(Nasdaq: SUPG ), a pharmaceutical company ... for solid tumors and,hematological malignancies, invites all interested parties ... Annual Analyst Day beginning at 9:30 a.m. ET,(6:30 a.m. ... on Tuesday,April 29, 2008., Investors and interested parties ...
... Renovis, Inc.,(Nasdaq: RNVS ), today announced that Glass ... ISS/Risk Metrics in recommending that Renovis,stockholders vote "FOR" the ... the Special Stockholders Meeting scheduled for May,1, 2008. In ... will be,converted into the right to receive the equivalent ...
... of Bioterrorism, Says UK Board ... Member General Lord Guthrie, BOSTON, April ... and deploy technology that can neutralize and destroy,a biohazardous substance while ... with General Lord Guthrie,former chief of the British Defense Staff, to ...
Other Biology Technology:Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 3Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 2Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 3
(Date:12/15/2009)... The 2009 Frost & Sullivan European Border ... Sagem Securite (Safran Group) for its innovative ... the company,s expertise in advanced biometric technology ... value-added products to end users. ,, ... Securite has been involved in delivering identification ...
(Date:12/15/2009)... As soon as babies are born, they are susceptible ... For up to a month, their immune systems aren,t ... often minor, they can lead to serious problems if ... of Missouri researchers have pinpointed a group of depleted ... vaccine. , "We,re trying to improve the immune system ...
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Researchers work on vaccine to improve immune system in newborns 2UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Oncolytics Biotech 28R 29 Inc Accelerates Warrant Expiry Date 14341 1Oncolytics Biotech 28R 29 Inc Accelerates Warrant Expiry Date 14341 2NIDDK announces availability of more current kidney disease data 58802 1NIDDK announces availability of more current kidney disease data 58802 2USC neuroscientists awarded 249 million to map gene expression during human brain development 58800 1USC neuroscientists awarded 249 million to map gene expression during human brain development 58800 2
... test for the two strains of human papillomavirus responsible for ... assay uses a cervical scraping, like that for a liquid-based ... responsible for 70 percent of cervical cancers, says Dr. Daron ... Cancer Prevention Center at the Medical College of Georgia. ...
... make cholesterol, a team of scientists has discovered ... production and potentially drug metabolism. , The collaborative ... of Medicine, Vanderbilt University, Indiana University and Eli ... of Cell Metabolism. , “Dap1 controls ...
... agriculture now will we meet the acute water-environment-poverty challenges facing ... land and human resources it is possible to produce enough ... food production and environmental trends will lead to crises in ... General of the International Water Management Institute. , This is ...
Other Biology News:New test for most virulent HPV strains under study 2New test for most virulent HPV strains under study 3Primitive yeast yields secrets of human cholesterol and drug metabolism 2Living with water scarcity -- world must act now 2Living with water scarcity -- world must act now 3Living with water scarcity -- world must act now 4Living with water scarcity -- world must act now 5
... up to 6 strain chambers with precise uniaxial ... design ensures that cells grow over long periods ... This unit allows you to control the frequency ... unique strain settings. The instrument fits in a ...
... The Guava PCA-96 systems provide automated, ... a tray of microcentrifuge tubes. This flexible ... ideal for screening in basic research, target ... Like it's smaller cousin, the Guava PCA-96 ...
... 250 g monoclonal antibody irreversibly crosslinked ... ~13 g of PDH complex from heart ... bovine heart mitochondria for control immunocapture. ,The ... isolation of PDH from small amounts of ...
... cells permits studies of protein-protein interactions, protein ... transcription factor-mediated gene regulation. The most rapid ... specific protein in a mammalian cell is ... cell. ProteoJuice Protein Transfection Reagent is an ...
Biology Products: